Associations between sex hormones and ASCVD in T2DM patients

Circulating luteinizing hormone and heart diseases in postmeopausal female patients with type 2 diabetes mellitus: a cross-sectional study

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100051100

Enrollment

Unknown

Registered

2021-09-13

Start date

2021-09-14

Completion date

Unknown

Last updated

2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus, heart diseases

Interventions

case series:no

Eligibility

Sex/Gender

Female

Age

45 Years to 84 Years

Inclusion criteria

Inclusion criteria: Female hospitalized T2DM patients with confirmed menopause or was >=60 years old or >=55 years old with FSH>=25mIU/mL with sex hormones measurement; having signed an informed consent form.

Exclusion criteria

Exclusion criteria: Participants with age >84 years, acute complications of T2DM, severe liver disease, malignant tumors, history of polycystic ovarian syndrome or pituitary tumor, or autoimmune disease.

Design outcomes

Primary

Measure	Time frame
high-sensitivity troponin T;	—

Countries

China

Contacts

Public ContactWang Yangang

Affiliated Hospital of Qingdao University

wangyg1966@126.com+86 18661807293

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026